Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: A behavioral analysis

Pharmacology

Volumn 78, Issue 4, 2006, Pages 193-197

  Baluchnejadmojarad, Tourandokht ^a   Roghani, Mehrdad ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Learning; Memory; Naringenin; Spatial cognition; Streptozotocin

Indexed keywords

NARINGENIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; ESTROGEN ANTAGONISTS; FLAVANONES; LEARNING; MALE; MEMORY; MEMORY DISORDERS; NEURODEGENERATIVE DISEASES; RATS; RATS, WISTAR; STREPTOZOCIN; TIME FACTORS;

EID: 33845609090     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096585     Document Type: Article

References (20)

1. Veerendra Kumar MH, Gupta YK: Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol 2003;30:336-342.
2. Standridge JB: Pharmacotherapeutic approaches to the prevention of Alzheimer's disease. Am J Geriatr Pharmacother 2004;2:119-132.
3. Grunblatt E, Hoyer S, Riederer P: Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease. J Neural Transm 2004;111:367-386.
4. Sharma M, Gupta YK: Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 2002;71:2489-2498.
5. Sonkusare S, Srinivasan K, Kaul C, Ramarao P: Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 2005;77:1-14.
6. Mercer LD, Kelly BL, Horne MK, Beart PM: Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol 2005;69:339-345.
7. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT: Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Rad Res 2005;39:1119-1125.
8. Heo HJ, Kim MJ, Lee JM, Choi SJ, Cho HY, Hong B, Kim HK, Kim E, Shin DH: Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement Geriatr Cogn Disord 2004;17:151-157.
9. Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH: Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection. J Agric Food Chem 2004;52:1520-1525.
10. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. San Diego, Academic Press, 1986.
11. Inokuchi J, Mizutani A, Jimbo M, Usuki S, Yamagishi K, Mochizuki H, Muramoto K, Kobayashi K, Kuroda Y, Iwasaki K, Ohgami Y, Fujiwara M: Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP). Biochem Biophys Res Commun 1997;237:595-600.
12. Lannert H, Hoyer S: Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998;112:1199-1208.
13. Fukui K, Omoi NO, Hayasaka T, Shinnkai T, Suzuki S, Abe K, Urano S: Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann NY Acad Sci 1998;959:275-284.
14. Carr DB, Goate A, Morris JC: Current concepts in the pathogenesis of Alzheimer's disease. Am J Med 1997;103:3S-10S.
15. Gasparin L, Rasshi M, Binetti G, Trabucchi M, Solerte SB, Alkon D, Etcheberrigary R, Gibson G, Blass J, Paletti R, Govoin S: Peripheral markers in testing pathophysiological hypothesis and diagnosing Alzheimer's disease. FASEB J 1998;12:17-34.
16. Zubenko GS, Moosy J, Martinez AJ, Rao GR, Kopp U, Hanin I: A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease. Arch Neurol 1989;46:634-638.
17. Law A, Gauthier S, Qurion L: Say No to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 2001;35:73-96.
18. Tariot PN, Federoff HJ: Current treatment for Alzheimer disease and future prospects. Alzheimer Dis Assoc Disord 2003;17:S105-S113.
19. Jiang F, Dusting G: Natural phenolic compounds as cardiovascular therapeutics:potential role of their anti-inflammatory effects. Curr Vasc Pharm 2003;1:135-156.
20. Chu WZ, Qian CY: Expressions of Abeta1-40, Abeta1-42, tau202, tau396 and tau404 after intracerebroventricular injection of streptozotocin in rats. Di Yi Jun Yi Da Xue Xue Bao 2005;25:168-170.